.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Chubb
McKesson
Citi
Moodys
Healthtrust
Daiichi Sankyo
Cerilliant
Cantor Fitzgerald

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073524

« Back to Dashboard
NDA 073524 describes EPITOL, which is a drug marketed by Teva and is included in two NDAs. It is available from ten suppliers. Additional details are available on the EPITOL profile page.

The generic ingredient in EPITOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.

Summary for NDA: 073524

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Anticonvulsants
Bipolar Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 073524

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPITOL
carbamazepine
TABLET, CHEWABLE;ORAL 073524 ANDA Teva Pharmaceuticals USA Inc 0093-0778 0093-0778-01 100 TABLET, CHEWABLE in 1 BOTTLE (0093-0778-01)
EPITOL
carbamazepine
TABLET, CHEWABLE;ORAL 073524 ANDA Mylan Institutional Inc. 51079-870 51079-870-20 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-870-20) > 1 TABLET, CHEWABLE in 1 BLISTER PACK (51079-870-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength100MG
Approval Date:Jul 29, 1992TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Baxter
Colorcon
Mallinckrodt
AstraZeneca
Citi
Express Scripts
Cipla
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot